Serial Number | 86790734 |
Word Mark | GLYCODX |
Filing Date | Friday, October 16, 2015 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 16, 2018 |
Registration Number | 5583190 |
Registration Date | Tuesday, October 16, 2018 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 31, 2018 |
Goods and Services | amino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for treatment of immune system related diseases, cancer and infectious diseases; reagent paper for medical purposes; medicated serums for treatment of immune system related diseases, cancer and infectious diseases; sugar for medical purposes; vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and antiangiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 21, 2015 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | OBI PHARMA, INC. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Taipei City 115011 TW |
Party Name | OBI PHARMA, INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Taipei City 115 R.O.C. TW |
Party Name | OBI PHARMA, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Taipei City 115 R.O.C. TW |
Event Date | Event Description |
Wednesday, March 27, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, March 27, 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
Wednesday, March 27, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, March 27, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, March 27, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, March 27, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Monday, October 16, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Tuesday, October 16, 2018 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 31, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 31, 2018 | PUBLISHED FOR OPPOSITION |
Wednesday, July 11, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, June 22, 2018 | 1(B) BASIS DELETED; NEW BASIS REQUESTED |
Friday, June 22, 2018 | NOTICE OF ALLOWANCE CANCELLED |
Thursday, June 21, 2018 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
Thursday, June 21, 2018 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
Thursday, June 21, 2018 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
Thursday, June 21, 2018 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
Tuesday, June 12, 2018 | TEAS RESPONSE TO PETITION INQUIRY LETTER |
Monday, June 4, 2018 | PETITION INQUIRY LETTER ISSUED |
Friday, June 1, 2018 | ASSIGNED TO PETITION STAFF |
Tuesday, May 1, 2018 | PAPER RECEIVED |
Friday, April 27, 2018 | TEAS PETITION TO AMEND BASIS RECEIVED |
Wednesday, March 28, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, March 26, 2018 | SOU EXTENSION 3 GRANTED |
Monday, March 26, 2018 | SOU EXTENSION 3 FILED |
Monday, March 26, 2018 | SOU TEAS EXTENSION RECEIVED |
Tuesday, February 20, 2018 | ASSIGNED TO EXAMINER |
Friday, October 6, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, October 4, 2017 | SOU EXTENSION 2 GRANTED |
Wednesday, October 4, 2017 | SOU EXTENSION 2 FILED |
Wednesday, October 4, 2017 | SOU TEAS EXTENSION RECEIVED |
Friday, March 10, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, March 8, 2017 | SOU EXTENSION 1 GRANTED |
Wednesday, March 8, 2017 | SOU EXTENSION 1 FILED |
Wednesday, March 8, 2017 | SOU TEAS EXTENSION RECEIVED |
Tuesday, October 25, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, August 30, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 30, 2016 | PUBLISHED FOR OPPOSITION |
Wednesday, August 10, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 26, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Thursday, July 21, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, July 19, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, July 19, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, July 14, 2016 | ASSIGNED TO LIE |
Friday, July 8, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, February 8, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, February 8, 2016 | NON-FINAL ACTION E-MAILED |
Monday, February 8, 2016 | NON-FINAL ACTION WRITTEN |
Monday, February 8, 2016 | ASSIGNED TO EXAMINER |
Wednesday, October 21, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 20, 2015 | NEW APPLICATION ENTERED |